Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone

MLA

Xiao-Feng Li, et al. “Development of a Chimeric Zika Vaccine Using a Licensed Live-Attenuated Flavivirus Vaccine as Backbone.” Nature Communications, vol. 9, no. 1, Feb. 2018, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41467-018-02975-w.

APA

Xiao-Feng Li, Hao-Long Dong, Hong-Jiang Wang, Xing-Yao Huang, Ye-Feng Qiu, Xue Ji, Qing Ye, Chunfeng Li, Yang Liu, Yong-Qiang Deng, Tao Jiang, Gong Cheng, Fu-Chun Zhang, Andrew D. Davidson, Ya-Jun Song, Pei-Yong Shi, & Cheng-Feng Qin. (2018). Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nature Communications, 9(1), 1–11. https://doi.org/10.1038/s41467-018-02975-w

Chicago

Xiao-Feng Li, Hao-Long Dong, Hong-Jiang Wang, Xing-Yao Huang, Ye-Feng Qiu, Xue Ji, Qing Ye, et al. 2018. “Development of a Chimeric Zika Vaccine Using a Licensed Live-Attenuated Flavivirus Vaccine as Backbone.” Nature Communications 9 (1): 1–11. doi:10.1038/s41467-018-02975-w.